1. Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med. 1999; 27:936–44.
Article
2. Giles GI. The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des. 2006; 12:4427–43.
Article
3. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene. 2004; 337:1–13.
Article
4. Noble M, Mayer-Pröschel M, Pröschel C. Redox regulation of precursor cell function: insights and paradoxes. Antioxid Redox Signal. 2005; 7:1456–67.
Article
5. Ito K, Hirao A, Arai F, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004; 431:997–1002.
Article
6. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007; 128:325–39.
7. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006; 12:446–51.
Article
8. Piccoli C, D'Aprile A, Ripoli M, et al. Bone-marrow derived hematopoietic stem/progenitor cells express multiple isoforms of NADPH oxidase and produce constitutively reactive oxygen species. Biochem Biophys Res Commun. 2007; 353:965–72.
Article
9. Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007; 110:3056–63.
Article
10. Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human cancers. Free Radic Biol Med. 2004; 36:718–44.
11. Li N, Oberley TD. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-over expressing NIH/3T3 fibroblasts during the cell cycle. J Cell Physiol. 1998; 177:148–60.
12. Kim A, Zhong W, Oberley TD. Reversible modulation of cell cycle kinetics in NIH/3T3 mouse fibroblasts by inducible over expression of mitochondrial manganese superoxide dismutase. Antioxid Redox Signal. 2004; 6:489–500.
13. Epperly MW, Bernarding M, Gretton J, Jefferson M, Nie S, Greenberger JS. Overexpression of the transgene for manganese superoxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNF-alpha, IL-3 withdrawal, and ionizing radiation. Exp Hematol. 2003; 31:465–74.
14. Epperly MW, Osipov AN, Martin I, et al. Ascorbate as a “redox sensor” and protector against irradiation-induced oxidative stress in 32D CL 3 hematopoietic cells and subclones over expressing human manganese superoxide dismutase. Int J Radiat Oncol Biol Phys. 2004; 58:851–61.
15. Southgate TD, Sheard V, Milsom MD, et al. Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase. J Gene Med. 2006; 8:557–65.
Article
16. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995; 11:376–81.
Article
17. Lebovitz RM, Zhang H, Vogel H, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA. 1996; 93:9782–7.
Article
18. Friedman JS, Rebel VI, Derby R, et al. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med. 2001; 193:925–34.
Article
19. Zhang Y, Smith BJ, Oberley LW. Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxid Redox Signal. 2006; 8:1283–93.
Article
20. Zhang HJ, Yan T, Oberley TD, Oberley LW. Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res. 1999; 59:6276–83.
21. Church SL, Grant JW, Ridnour LA, et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA. 1993; 90:3113–7.
Article
22. Liu R, Oberley TD, Oberley LW. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum Gene Ther. 1997; 8:585–95.
Article
23. Li N, Oberley TD, Oberley LW, Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate. 1998; 35:221–33.
Article
25. Rodriguez AM, Carrico PM, Mazurkiewicz JE, Me-léndez JA. Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H (2)O(2). Free Radic Biol Med. 2000; 29:801–13.